D&O Ongoing Disclosure – Scott Coulter

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Comvita Limited
Date this disclosure made:
17-Mar-20
Date of last disclosure:
9-Mar-20
Director or senior manager giving disclosure
Full name(s):
Scott Philip Coulter
Name of listed issuer:
Comvita Limited
Name of related body corporate (if applicable):
n/a
Position held in listed issuer:Former Chief Executive Officer - left Comvita
30 September 2019
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares
Nature of the affected relevant interest(s):Scott Philip Coulter - registered holder
SKPR Holdings Limited - power to exercise,
right to vote and power to acquire or dispose of
the product
For that relevant interest-
Number held in class before acquisition or disposal:Scott Philip Coulter - 218,567
SKPR Holdings Limited - 123,408
Number held in class after acquisition or disposal:Scott Philip Coulter - 218,567
SKPR Holdings Limited - 78,077
Current registered holder(s):Scott Philip Coulter
SKPR Holdings Limited
Registered holder(s) once transfers are registered:
Same as current registered holders
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
Multiple
Nature of transaction: SKPR Holdings Limited - sale of ordinary
shares on market
Name of any other party or parties to the transaction (if known):n/a
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value, describe the consideration:
SKPR Holdings Limited - $88,000.75 sale of
shares
Number of financial products to which the transaction related: 45,331
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
n/a
Date of the prior written clearance (if any):
n/a
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:
17-Mar-20